Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome
Sublingual melatonin may be administered to IBS patients as a complementary treatment to alleviate symptoms and improve QoL.
Authors
- Mohammad Abbasinazari (ORCID: https://orcid.org/0000-0001-6414-5557)
- Niloofar Namazi
- Arash Mahboubi (ORCID: https://orcid.org/0000-0002-5140-8159)
- Shabnam Shahrokh (ORCID: https://orcid.org/0000-0002-3420-5608)
- Amir Sadeghi (ORCID: https://orcid.org/0000-0002-9580-2676)
- Ali Abazarikia
Institutions
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian journal of pharmaceutical research
- Published
- 2025-02-15
- DOI
- https://doi.org/10.5812/ijpr-156425
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00